Skip to main content
Clinical Trials/NCT03217461
NCT03217461
Completed
Not Applicable

A Non-randomized Controlled Clinical Trial of Corneal Autograft for Limbal Dermoid

Chunxiao Wang1 site in 1 country19 target enrollmentMay 10, 2022
ConditionsCorneal Dermoid

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Corneal Dermoid
Sponsor
Chunxiao Wang
Enrollment
19
Locations
1
Primary Endpoint
Corneal Thickness
Status
Completed
Last Updated
10 months ago

Overview

Brief Summary

To investigate the clinical efficacy of femtosecond laser-assisted autologous lamellar keratoplasty in treating corneal dermoids.

Registry
clinicaltrials.gov
Start Date
May 10, 2022
End Date
November 29, 2024
Last Updated
10 months ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Chunxiao Wang
Responsible Party
Sponsor Investigator
Principal Investigator

Chunxiao Wang

Clinical investigator

Sun Yat-sen University

Eligibility Criteria

Inclusion Criteria

  • Age between 5 to 35 years old,
  • Patients with limbal dermoid, scheduled for elective surgical excision,
  • The distance of less than 5 mm of lesion encroachment into the cornea,
  • The participant or their legal guardian has voluntarily chosen to participate in this study, has signed the informed consent form, and has demonstrated a high level of adherence to the study protocols and cooperation throughout the follow-up process.

Exclusion Criteria

  • Keratoconus,
  • High myopia with a spherical equivalent of -15.0 D or less,
  • Ocular and facial active inflammation such as keratitis, trachoma, dacryocystitis, blepharitis, meibomian gland dysfunction, Sjogren's syndrome, cicatricial pemphigoid etc,
  • Corneal or ocular surface infection within 30 days prior to study entry,
  • Severe cicatricial eye disease,
  • Ocular surface malignancy,
  • Ocular comorbidities that affect the prognosis of transplantation, such as advanced glaucoma or retinal diseases,
  • History of allo-limbal transplantation, penetrating keratoplasty or anti-glaucoma filtering surgeries,
  • Uncontrolled diabetes with most recent Hemoglobin A1c greater than 8.5%,
  • Renal failure with creatinine clearance\< 25ml/min,

Outcomes

Primary Outcomes

Corneal Thickness

Time Frame: 1 week, 1 month, 3 months, 6 months, 9 months, 12 months and 18 months postoperatively

To measure corneal thickness using anterior segment optical coherence tomography.

Corneal Transparency

Time Frame: Preoperatively, 1 week, 1 month, 3 months, 6 months, 9 months, 12 months and 18 months postoperatively

The transparency and appearance of the cornea will be observed using slit-lamp microscopy

Secondary Outcomes

  • Best corrected visual acuity(Preoperatively, 1 week, 1 month, 3 months, 6 months, 9 months, 12 months and 18 months postoperatively)
  • Corneal power, astigmatism and aberration(Preoperatively, 1 week, 1 month, 3 months, 6 months, 9 months, 12 months and 18 months postoperatively)
  • Cosmetic improvement(Preoperatively, 1 week, 1 month, 3 months, 6 months, 9 months, 12 months and 18 months postoperatively)

Study Sites (1)

Loading locations...

Similar Trials